YBX2 and colorectal carcinoma: HEATR3 (Diff = − 0.22; p = 7.61 × 10− 7) and YBX2 (Diff = − 0.19; p = 5.67 × 10− 6) transcripts exhibited statistically significant shortening, which was associated with worse survival of CRC patients (Fig. 5c; HEATR3: log-rank test, p = 0.0033; YBX2: log-rank test, p = 3.0 × 10− 4).